Alk1/Endoglin signaling restricts vein cell size increases in response to hemodynamic cues

被引:0
|
作者
Diwan, Zeenat [1 ]
Kang, Jia [1 ,2 ]
Tsztoo, Emma [1 ]
Siekmann, Arndt F. [1 ]
机构
[1] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, 1114 Biomed Res Bldg,421 Curie Blvd, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA
关键词
Endoglin; Alk1; Hereditary hemorrhagic telangiectasia; Shear Stress Set Point; Endothelial Cell Size; Artery; Vein; Zebrafish; CAUSES ARTERIOVENOUS-MALFORMATIONS; ENDOTHELIAL-CELLS; STEM-CELLS; PROTEIN; MUTATIONS; ENDOGLIN; NETWORK; GENE; ULTRASTRUCTURE; EXPRESSION;
D O I
10.1007/s10456-024-09955-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hemodynamic cues are thought to control blood vessel hierarchy through a shear stress set point, where flow increases lead to blood vessel diameter expansion, while decreases in blood flow cause blood vessel narrowing. Aberrations in blood vessel diameter control can cause congenital arteriovenous malformations (AVMs). We show in zebrafish embryos that while arteries behave according to the shear stress set point model, veins do not. This behavior is dependent on distinct arterial and venous endothelial cell (EC) shapes and sizes. We show that arterial ECs enlarge more strongly when experiencing higher flow, as compared to vein cells. Through the generation of chimeric embryos, we discover that this behavior of vein cells depends on the bone morphogenetic protein (BMP) pathway components Endoglin and Alk1. Endoglin (eng) or alk1 (acvrl1) mutant vein cells enlarge when in normal hemodynamic environments, while we do not observe a phenotype in either acvrl1 or eng mutant ECs in arteries. We further show that an increase in vein diameters initiates AVMs in eng mutants, secondarily leading to higher flow to arteries. These enlarge in response to higher flow through increasing arterial EC sizes, fueling the AVM. This study thus reveals a mechanism through which BMP signaling limits vein EC size increases in response to flow and provides a framework for our understanding of how a small number of mutant vein cells via flow-mediated secondary effects on wildtype arterial ECs can precipitate larger AVMs in disease conditions, such as hereditary hemorrhagic telangiectasia (HHT).
引用
收藏
页数:15
相关论文
共 14 条
  • [1] Enhanced ALK1 signaling inhibits arteriovenous malformations caused by endoglin deficiency
    Kim, Y.
    Phuong, N.
    Calvin, P. H., V
    Arthur, H.
    Lee, Y. J.
    Oh, S. P.
    ANGIOGENESIS, 2019, 22 (04) : 589 - 589
  • [2] Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
    Lebrin, F
    Goumans, MJ
    Jonker, L
    Carvalho, RLC
    Valdimarsdottir, G
    Thorikay, M
    Mummery, C
    Arthur, HM
    ten Dijke, P
    EMBO JOURNAL, 2004, 23 (20): : 4018 - 4028
  • [3] Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension
    Gore, Benoit
    Izikki, Mohamed
    Mercier, Olaf
    Dewachter, Laurence
    Fadel, Elie
    Humbert, Marc
    Dartevelle, Philippe
    Simonneau, Gerald
    Naeije, Robert
    Lebrin, Franck
    Eddahibi, Saadia
    PLOS ONE, 2014, 9 (06):
  • [4] Consequences of Alteration in TGF-β/ALK1/endoglin Signaling in the Pathogenesis of Human and Rodent Pulmonary Arterial Hypertension.
    Gore, B.
    Dewachter, L.
    Tu, L.
    Fadel, E.
    Humbert, M.
    Lebrin, F.
    Guignabert, C.
    Eddahibi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [5] L- and S-endoglin differentially modulate TGFβ1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts
    Velasco, Soraya
    Alvarez-Munoz, Patricia
    Pericacho, Miguel
    ten Dijke, Peter
    Bernabeu, Carmelo
    Lopez-Novoa, Jose M.
    Rodriguez-Barbero, Alicia
    JOURNAL OF CELL SCIENCE, 2008, 121 (06) : 913 - 919
  • [6] ALK1 HETEROZYGOUS DISRUPTION IMPAIRS TGF-β/SMAD SIGNALING AND INCREASES RENAL FIBROSIS FOLLOWING URETERAL OBSTRUCTION
    Munoz-Felix, Jose M.
    Lopez-Novoa, Jose M.
    Martinez-Salgado, Carlos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 189 - 189
  • [7] Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
    Eleftheriou, Nikolas M.
    Sjolund, Jonas
    Bocci, Matteo
    Cortez, Eliane
    Lee, Se-Jin
    Cunha, Sara I.
    Pietras, Kristian
    ONCOTARGET, 2016, 7 (51): : 84314 - 84325
  • [8] Cerebrovascular Dysplasia in Endoglin and Alk1 Haploinsufficient Mice After VEGF Stimulation: Evidence for a "Response-to-Injury" Hypothesis for Hereditary Hemorrhagic Telangectasia
    Hao, Qi
    Zhu, Yiqian
    Shen, Fanxia
    Yang, Guo-Yuan
    Su, Hua
    Young, William L.
    STROKE, 2010, 41 (04) : E264 - E264
  • [9] Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
    Wang, Xiaoen
    Solban, Nicolas
    Khanna, Prateek
    Callea, Marcella
    Song, Jiaxi
    Alsop, David C.
    Pearsall, R. Scott
    Atkins, Michael B.
    Mier, James W.
    Signoretti, Sabina
    Alimzhanov, Marat
    Kumar, Ravi
    Bhasin, Manoj K.
    Bhatt, Rupal S.
    ONCOTARGET, 2016, 7 (27) : 41857 - 41869
  • [10] Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting
    van Meeteren, Laurens A.
    Thorikay, Midory
    Bergqvist, Simon
    Pardali, Evangelia
    Stampino, Corrado Gallo
    Hu-Lowe, Dana
    Goumans, Marie-Jose
    ten Dijke, Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (22) : 18551 - 18561